CAS: 85-85-8; 1-(2-Pyridylazo)-2-Naphthol

相似化合物

1141-59-9 842-07-9 85-86-9

上下游产品

CAS号41122-56-9 Sodium pyridyld... | CAS号135-19-3 2-萘酚 | CAS号1198-27-2 1-氨基-2-萘酚盐酸盐

Sodium 2-Pyridyldiazotate,2-萘酚置于sodium Hydroxide体系中,用 甲醇 作为反应溶剂,化学反应 210.0H,以54.6%的收率获得产物1-(2-吡啶偶氮)-2-萘酚
参考文献:Wiejak,Stanislaw; Pasternak,Ewaryst E.; Tomasik,Piotr,Polish Journal Of Chemistry,1984,Vol. 58,# 7-8-9,P. 895-897
标题:Wiejak,Stanislaw; Pasternak,Ewaryst E.; Tomasik,Piotr,Polish Journal Of Chemistry,1984,Vol. 58,# 7-8-9,P. 895-897

专利信息

专利号:US-12007376-B2
优先权日:2014-02-26
标题 :Method for determining a concentration of a synthesis component in a radiopharmaceutical sample
发明人：LEBEDEV ARTEM Y; ELIZAROV ARKADIJ M
权利人:TRACE ABILITY INC
摘要:A method for determining a concentration of a synthesis component in a radiopharmaceutical sample comprises providing an indicator, a metal or a metal complex, contacting the radiopharmaceutical sample with the indicator, metal or metal complex for a period of time sufficient to obtain an interaction, measuring an optical characteristic of the interacted components, and determining a concentration of the synthesis component in the radiopharmaceutical sample based on the measured optical characteristic.

专利号:US-2025162985-A1
优先权日:2023-11-21
标 题 :Composition and process of elaboration of non-hydrolyzable surfactants from vegetable oils
发明人：CANTO IBANEZ JORGE JOAQUIN; MARTINEZ MARTINEZ DE LA ESCALERA LORENZO; NERI ADRIAN CRISTOBAL; MATLA BAEZ ABRAHAM; BARRERA SANCHEZ GUILLERMO; MONTELONGO VILLAR JOSE LUIS
权利人:CORROSION Y PROTECCION S A DE C V
摘要:Chemical additives for the stimulation of oil wells and their formulations. The invention discloses a micelle-forming surface tension modifying agent, as well as synthesis processes, to be used to modify rock permeability, which supports pressure and temperature under well conditions. The formulation has as an additional advantage, that it is made up, in most of its components, with ingredients derived from natural origin and that it does not present hydrolysis phenomenon at the well working temperature, it is highly compatible with high pressure and it can be recover for a reinjection. The invention can be used in different proportions of formulations for stimulating oil wells.

专利号:US-6602989-B1
优先权日:2000-05-17
标题:Synthesis, characterization, and application of pyridylazo bioconjugates as diagnostic and therapeutic agents
发明人：SADIK OMOWUNMI A; XU HONGWU
权利人:UNIV NEW YORK STATE RES FOUND
摘要:The detection of gallium in biological samples is required due to its role in the diagnosis of tumor and for possible treatment of malignancies. However, the use of purely instrumental techniques is unsuitable for detection of low levels of gallium in biological matrices. New protein conjugates have been synthesized based on 4-(2-pyridylazo) ligands. The conjugates detect gallium in biological matrices using a non antibody-based sandwich assay format. The recovery level is between 97-101.3 with a relative standard deviation of less than 5%. The assay results in a detection limit of 5×10 −8 M and a remarkable selectivity for gallium(III) relative to other metals investigated. The new method provides adequate accuracy for gallium applicable for animal physiology and clinical toxicology.

专利号:US-10309947-B2
优先权日:2013-02-27
标题:System and method for radiosynthesis, quality control and dose dispensing
发明人：ELIZAROV ARKADIJ; LEBEDEV ARTEM
权利人:TRACE ABILITY INC
摘要:A system and method for performing radiochemical synthesis, analysis and/or dispensing of radiopharmaceuticals using specially designed disposable components: palettes and caddies, the palette being an assembly of containers not connected with each other for direct material transfer; the caddy being a disposable component used to transfer material between containers on the palettes and/or other locations.

专利号:US-2021102929-A1
优先权日:2014-02-26
标题:Method for determining a concentration of a synthesis component in a radiopharmaceutical sample

专利号:JP-2024512568-A
优先权日:2021-03-25
标 题:Enamine N-oxide: synthesis and application of hypoxia-responsive prodrugs and contrast agents